No CrossRef data available.
Article contents
Dementia care in nursing homes: a golden opportunity
Published online by Cambridge University Press: 30 January 2014
Extract
The paper by Kleijer and colleagues (2014) in this issue of International Psychogeriatrics describes factors that may influence antipsychotic drug (APD) prescribing rates in nursing homes in several countries. The authors conclude that the large variability is only partly explained by differences in resident characteristics, and that it is associated with certain facility characteristics such as bed size and urban/rural location. They also identify the likelihood that differences in physician prescribing patterns or facility prescribing culture may influence APD prescribing rates, as has been found in previous studies (Briesacher et al., 2005; Chen et al., 2010).
- Type
- Commentary Paper of the Month
- Information
- Copyright
- Copyright © International Psychogeriatric Association 2014
References
Avorn, J.
et al. (1992). A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. New England Journal of Medicine, 327, 168–173.CrossRefGoogle ScholarPubMed
Bowblis, J. R., Crystal, S., Intrator, O. and Lucas, J. A. (2012). Response to regulatory stringency: the case of antipsychotic medication use in nursing homes. Health Economics, 21, 977–993. doi:10.1002/hec.1775.CrossRefGoogle ScholarPubMed
Briesacher, B. A.
et al. (2005). The quality of antipsychotic drug prescribing in nursing homes. Archives of Internal Medicine, 165, 1280–1285. doi:10.1001/archinte.165.11.1280.CrossRefGoogle ScholarPubMed
Brownie, S. (2011). A culture change in aged care: the Eden alternative. Australian Journal of Advanced Nursing, 29, 63–68.Google Scholar
Castle, N. G., Engberg, J. and Men, A. (2007). Variation in the use of nursing home deficiency citations. Journal for Healthcare Quality, 29, 12–23.CrossRefGoogle ScholarPubMed
Castle, N. G., Hanlon, J. T. and Handler, S. M. (2009). Results of a longitudinal analysis of national data to examine relationships between organizational and market characteristics and changes in antipsychotic prescribing in US nursing homes from 1996 through 2006. American Journal of Geriatric Pharmacotherapy, 7, 143–150. doi:10.1016/j.amjopharm.2009.05.001.CrossRefGoogle ScholarPubMed
Chen, Y., Briesacher, B. A., Field, T. S., Tjia, J., Lau, D. T. and Gurwitz, J. H. (2010). Unexplained variation across US nursing homes in antipsychotic prescribing rates. Archives of Internal Medicine, 170, 89–95. doi:10.1001/archinternmed.2009.469.CrossRefGoogle ScholarPubMed
Crystal, S., Olfson, M., Huang, C., Pincus, H. and Gerhard, T. (2009). Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. Health Affairs (Millwood), 28, w770–w781. doi:10.1377/hlthaff.28.5.w770.CrossRefGoogle ScholarPubMed
Edvardsson, D., Sandman, P. O. and Rasmussen, B. (2009). Construction and psychometric evaluation of the Swedish language Person-Centred Climate Questionnaire – staff version. Journal of Nursing Management, 17, 790–795. doi:10.1111/j.1365-2834.2009.01005.x.CrossRefGoogle ScholarPubMed
Gitlin, L. N., Kales, H. C. and Lyketsos, C. G. (2012). Nonpharmacologic management of behavioral symptoms in dementia. JAMA, 308, 2020–2029. doi:10.1001/jama.2012.36918.CrossRefGoogle ScholarPubMed
Grabowski, D. C. (2011). Comparing the Green House Model with Traditional Nursing Homes on Cost and Quality of Care. Princeton, NJ: Robert Wood Johnson Foundation.Google Scholar
Kleijer, B. C.
et al. (2014). Variability between nursing homes in prevalence of antipsychotic use in patients with dementia. International Psychogeriatrics, 26, 363–371.CrossRefGoogle ScholarPubMed
O’Neil, M., Freeman, M., Christensen, V., Telerant, A., Addleman, A. and Kansagara, D. (2011). Non-Pharmacological Interventions for Behavioral Symptoms of Dementia: a Systematic Review of the Evidence. VA-ESP Project #05-225 Report; 2011, Portland, OR.Google Scholar
Wehry, S. (2012). Oasis 1.3 Training Manual (Massachusetts Senior Care, CMS Partnership Initiative to Improve Dementia Care). Montpelier, VT: Vermont Health Care Association.Google Scholar
White, D. L., Newton-Curtis, L. and Lyons, K. S. (2008). Development and initial testing of a measure of person-directed care. Gerontologist, 48, 114–123.CrossRefGoogle ScholarPubMed